Bullish Kumo Breakout w/bullish TK cross after a multi-year down trend. Bullish Kumo twist likely to follow over the next few days.
Pfizer ( NYSE:PFE ) has won $107.5 million in damages from AstraZeneca in a US cancer drug patent trial. A Delaware federal jury found that AstraZeneca's lung cancer drug Tagrisso violated its Wyeth unit's patent rights. The jury agreed that AstraZeneca's drug infringed two patents covering methods for treating cancer with the breast-cancer drug Nerlynx, which is...
Reasons for bullish bias: - The price has broken the downtrend trendline - An entry at the lower highs (LH) breakout will provide further confirmation - Currently, the price is in a consolidation phase Here are the recommended trading levels: Entry Level(Buy stop): 30.18 Stop Loss Level: 25.26 Take Profit Level 1: 35.1 Take Profit Level 2: 40.02 Take Profit Level 3: Open
NYSE:PFE Pfizer made a classic reversal and is now in retraction before next move up. Is a long-mid time trade, anyway you will have around 6% dividends on your way as reward for waiting.
We have everything in place… A double bottom A channel down breakout An inverted head and shoulder forming out
Reasons for bullish bias: - Entry at accumulation phase breakout - Bullish Harmonic XABCD pattern on weekly - Strong weekly Bullish divergence - Price broke strong downtrend trendline - Strong bullish weekly candles at support - Positive Earnings Here are the recommended trading levels: Entry Level(CMP): 28.91 Stop Loss Level: 24.65 Take Profit Level 1:...
I've used a few methods to understand potential price movement on NYSE:PFE , including a fib pitchfork, going back to 1972 as well as key support levels. I believe we're oversold and consolidating, soon to start the journey to ATH at the $75 level
Hello everyone, today I want to discuss Pfizer's stock which experienced a 58% correction from its peak price and is currently trading around $26. I believe this stock has a lot of potential for both scalpers and long-term investors. With a dividend yield of 6.65% at this price, it's an attractive investment option. Additionally, the earnings report due this week...
Here I am again with another trade. Pfizer is one of the many stocks I have been following for quite a time waiting for a good setup and I think now it's the time to go long, Bullish RSI divergence, probable double bottom on a long time strong support area. We know this company has received a lot of heat because of covid, but Pfizer is a strong player in the...
Price has broken out of the downward trend. Looks prime to continue upward momentum. RSI's trending up MACD up Are you buying?
Very clear picture on NYSE:PFE on a weekly timeframe If it stays above the centre line, the trend is up and I have an initial target of around $35 If takes out the protective stock we have a continuation of the downtrend and this was just a minor upward correction. Risk/Reward ratio 2.90 What's your take on NYSE:PFE from here? Up or Down
PFE weekly data is conveying significant accumulation at the current price range. Net positive volume has been increasing on a daily basis for the past few days -- in anticipation of the company's incoming price growth, long term. The stock is currently sitting at 78.6 FIB level -- a discounted level where buyers converge. Expect some significant bounce from...
PFE has broken out of the downtrend line of 1-year 4 months and has been forming an accumulation. The bullish morning star formation is indicative of a potential rebound going forward. Expect a strong rebound!
Pfizer, Inc. (PFE) has shown a notable rebound in its stock price, as observed in the latest trading sessions. This analysis delves into various technical indicators and chart patterns to forecast future price movements and provide strategic trading recommendations. PFE has recently experienced a bullish surge, evident from the significant green candle that broke...
We're in this from a bit higher. Still holding. We think it's bottoming here. TP 46% from our entry. ~ 56% from here. Would love to swing a weekly SFP today for confirmation, but not really necessary. LTF looks good.
Pfizer Inc idea Safe to enter above $27.18 we may see a new low below $25 Technicals are on positive side..
Pfizer Inc. ( NYSE:PFE ) sent shockwaves through the market with a stunning first-quarter performance, catapulting its stock price upward following a robust quarterly beat that surpassed analysts' expectations by a wide margin. The pharmaceutical giant reported adjusted earnings of 82 cents per share, significantly outpacing the forecasted 51 cents per share, and...
In a landmark decision, the Food and Drug Administration (FDA) has given its stamp of approval to Pfizer's groundbreaking gene therapy for hemophilia B, marking a pivotal moment in the field of genetic medicine. Hemophilia B, a rare inherited bleeding disorder affecting thousands in the U.S., has long posed significant challenges for patients and caregivers due to...